Physician profile
Vincent Dalessandro
NPI 1023000221
$282.42
in general payments reported to CMS, 2019-2025
8 companies · $89.62 in 2025
The $89.62 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.77 · 2022: $16.97 · 2023: $57.72 · 2024: $91.34 · 2025: $89.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $48.55 | 2022-2025 | Trulicity, Mounjaro, Jardiance |
| Abbott Laboratories | $44.32 | 2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $43.04 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $39.02 | 2021-2025 | |
| Pfizer INC. | $34.74 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $28.68 | 2025 | Rexulti |
| Amgen INC. | $25.65 | 2023 | Repatha |
| Exact Sciences Corporation | $18.42 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Dalessandro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.